Author:
Santos Andreia A,Lopes Célia C,Ribeiro Jorge R,Martins Liliana R,Santos Joana C,Amorim Irina F,Gärtner Fátima,Matos Augusto J
Abstract
Abstract
Background
Although several histopathological and clinical features of canine mammary gland tumours have been widely studied from a prognostic standpoint, considerable variations in tumour individual biologic behaviour difficult the definition of accurate prognostic factors. It has been suggested that the malignant behaviour of tumours is the end result of several alterations in cellular physiology that culminate in tumour growth and spread. Accordingly, the aim of this study was to determine, using a multivariable model, the independent prognostic value of several immunohistochemically detected tumour-associated molecules, such as MMP-9 and uPA in stromal cells and Ki-67, TIMP-2 and VEGF in cancer cells.
Results
Eighty-five female dogs affected by spontaneous malignant mammary neoplasias were followed up for a 2-year post-operative period. In univariate analysis, tumour characteristics such as size, mode of growth, regional lymph node metastases, tumour cell MIB-1 LI and MMP-9 and uPA expressions in tumour-adjacent fibroblasts, were associated with both survival and disease-free intervals. Histological type and grade were related with overall survival while VEGF and TIMP-2 were not significantly associated with none of the outcome parameters. In multivariable analysis, only a MIB-1 labelling index higher than 40% and a stromal expression of MMP-9 higher than 50% retained significant relationships with poor overall and disease-free survival.
Conclusions
The results of this study indicate that MMP-9 and Ki-67 are independent prognostic markers of canine malignant mammary tumours. Furthermore, the high stromal expressions of uPA and MMP-9 in aggressive tumours suggest that these molecules are potential therapeutic targets in the post-operative treatment of canine mammary cancer.
Publisher
Springer Science and Business Media LLC
Subject
General Veterinary,General Medicine
Reference40 articles.
1. Lana SE, Rutteman GR, Withrow SJ: Tumors of the mammary gland. Small Animal Clinical Oncology. 4th edition. Edited by: Withrow SJ, MacEwen EG. St. Louis: Saunders Elsevier, 2007, 619-636.
2. Sorenmo K: Canine mammary gland tumors. Vet Clin North Am Small Anim Pract. 2003, 33: 573-596. 10.1016/S0195-5616(03)00020-2.
3. Misdorp W, Else RW, Helmén E, Lipscomb TP: Histological classification of the mammary tumours of the dog and the cat. World Health Organization International Histological Classification of Tumours of Domestic Animals. 2nd edition. Edited by: Shulman FL. Washington DC: Armed Forces Institute of Pathology, 1999, 16-29.
4. De Las Mulas J, Millán Y, Dios R: A prospective analysis of immunohistochemically determined estrogen receptor α and progesterone receptor expression and host and tumor factors as predictors of disease-free period in mammary tumors of the Dog. Vet Pathol. 2005, 42: 200-212. 10.1354/vp.42-2-200.
5. Ferreira E, Bertagnolli AC, Cavalcanti MF, Schmitt FC, Cassali GD: The relationship between tumour size and expression of prognostic markers in benign and malignant canine mammary tumours. Vet Comp Oncol. 2009, 7: 230-235. 10.1111/j.1476-5829.2009.00193.x.
Cited by
96 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献